Vaxigrip Formulation: Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/2570/2019 (HINI)pdm09-like stra
Country: Philippines
Language: English
Source: FDA (Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Trivalent Seasonal Influenza Vaccine (Split Virion, Inactivated) 2022 Southern Hemisphere Strain
Available from:
Sanofi Pasteur, Inc.; Distributor: Zuellig Pharma Corporation
INN (International Name):
Trivalent Seasonal Influenza Vaccine (Split Virion, Inactivated) 2022 Southern Hemisphere Strain
Dosage:
Formulation: Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/2570/2019 (HINI)pdm09-like strain 15 ug
Pharmaceutical form:
Suspension for Injection (IM/SC)
Units in package:
Multidose (10 doses). 5 mL Type I glass vial (Box of 10's), 5 mL Type I glass vial (Box of 10's). Multidose: 10 doses, 5mL G
Manufactured by:
Sanofi Pasteur, France
Authorization date:
2022-03-24
